GlassScriptPhysician profile
Larry Thomas Watts
NPI 1508979568
$7,316.80
in general payments reported to CMS, 2019-2025
11 companies · $674 in 2025
The $674 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $380 · 2020: $199 · 2021: $193 · 2022: $2,413 · 2023: $558 · 2024: $2,900 · 2025: $674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,240 · Travel and Lodging: $1,891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,240.35 |
| Travel and Lodging | $1,891.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,160.35 | 2021-2025 | Avalus, Simulus, Penditure |
| Edwards Lifesciences Corporation | $2,591.39 | 2019-2025 | Mitris Resilia Mitral Valve |
| Transmedics, INC. | $522.46 | 2022 | |
| Abbott Laboratories | $342.92 | 2019-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $285.35 | 2019-2024 | Impella |
| Paragonix Technologies, INC. | $257.26 | 2020-2022 | |
| Lsi Solutions INC | $48.78 | 2022-2023 | Cor Knot |
| Peerless Surgical INC. | $44.26 | 2024 | |
| Lemaitre Vascular, INC. | $24.08 | 2025 | Hydro Lemaitre Valvulotome |
| Medtronic Vascular, INC. | $23.32 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $16.63 | 2024 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Watts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.